Atazanavir-TL (Atazanavir-TL)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substanceAtazanavirAtazanavir
Similar drugsTo uncover
  • Atazanavir Canon
    capsules inwards 
    CANONFARMA PRODUCTION, CJSC     Russia
  • Atazanavir-TL
    capsules inwards 
    TECHNOLOGY OF DRUGS, LTD.     Russia
  • Reatase®
    capsules inwards 
    Bristol-Myers Squibb Company     USA
  • Reatase®
    capsules inwards 
    Bristol-Myers Squibb Company     USA
  • Simanod
    capsules inwards 
    FARMASINTEZ, JSC (Irkutsk)     Russia
    • Dosage form: & nbspcapsules
    ATX: & nbsp

    J.05.A.E.   Protease Inhibitors

    J.05.A.E.08   Atazanavir

    Terms of leave from pharmacies:On prescription
    Registration number:LP-004872
    Date of registration:30.05.2018
    Expiration Date:30.05.2023
    The owner of the registration certificate:TECHNOLOGY OF DRUGS, LTD. TECHNOLOGY OF DRUGS, LTD. Russia
    Manufacturer: & nbsp
    Information update date: & nbsp21.06.2018
    Illustrated instructions
      Instructions
      Up
      talkdrugs

      +8 (800)555-35-35

      [email protected]

      The reference book of medicines of the Publishing Group "GEOTAR-Media" - the leader in the field of professional medical and pharmaceutical literature.

      The information on the preparations placed on the site is intended only for specialists. Drug descriptions can not be used by patients to make an independent decision on their use.

      It is forbidden to copy any instructions of medicines,biologically active additives or other information from the site www.talkdrugs.info without the written permission of the Publishing House "GEOTAR".

      All rights reserved. © Publishing group "GEOTAR-Media" 2008-2016.